| Heidelbe. | 2,99 € | +0,34% | ||
| CO.DON . | 0,0165 € | 0,00% | ||
| BB Biote. | 48,05 ¤ | 0,00% | ||
| Evotec SE | 6,168 € | -0,64% | ||
| Sartorius. | 256,20 € | -1,46% | ||
| 2Invest AG | 11,00 € | -1,79% | ||
| Pentixap. | 1,948 € | -2,01% | ||
| Qiagen NV | 45,485 € | -2,04% | ||
| Sartorius. | 197,60 € | -2,42% | ||
| Medigen. | 0,0342 € | -7,57% |
| Paion AG | 0,0126 € | -32,98% | ||
| Medigen. | 0,0342 € | -7,57% | ||
| Sartorius. | 197,60 € | -2,42% | ||
| Qiagen NV | 45,485 € | -2,04% | ||
| Pentixap. | 1,948 € | -2,01% | ||
| 2Invest AG | 11,00 € | -1,79% | ||
| Sartorius. | 256,20 € | -1,46% | ||
| Evotec SE | 6,168 € | -0,64% | ||
| CO.DON . | 0,0165 € | 0,00% | ||
| BB Biote. | 48,05 ¤ | 0,00% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Xetra | 600,71 | -1,66% | 610,83 | 28.01.26 | |
| Aktie | Marktkap. in Mio. € | Anzahl Jahre Outperformance | Performance Ø |
|---|---|---|---|
| Sartorius AG Vz | 8.771,95 | 7 | +22,72% |
| Heidelberg Pharma AG | 139,87 | 5 | +17,38% |
| Evotec SE | 2.183,47 | 5 | +17,33% |
| Datum | Kurs |
|---|---|
| 27.01.26 | 610,83 |
| 26.01.26 | 617,41 |
| 23.01.26 | 618,58 |
| 22.01.26 | 621,09 |
| 21.01.26 | 611,36 |
| Name | Letzter | Performance | |
|---|---|---|---|
| DAX | 24.894 | -0,15% | |
| Nasdaq 100 | 25.940 | +0,88% | |
| Dow Jones Industrial. | 49.003 | -0,83% | |
| S&P 500 | 6.979 | +0,40% | |
| MDAX (Perf.) | 31.728 | -0,31% | |
| MSCI World | 4.556 | +0,62% | |
| TecDAX (Perf.) | 3.713 | -0,46% | |
| SDAX (Perf.) | 18.328 | -0,26% | |
| DAX (Kurs) | 9.327 | -0,15% | |
| Euro Stoxx 50 | 5.995 | +0,62% |
| Wertpapier | Beiträge | Perf. |
| Evotec SE | 2 | - |